secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0001193125-23-014221
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Leone Patterson resigns from Eliem Therapeutics board
--------------------------------------------------------------

- Leone Patterson resigned from the Board effective Jan 19, 2023, citing no disagreement on operations.
- Board size reduced from 7 to 6 directors.
- Audit Committee reconstituted: Adam Rosenberg (Chair), Simon Tate, Judith Dunn.
- Nominating and Corp Gov Committee: Simon Tate (Chair), Liam Ratcliffe.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312523014221/0001193125-23-014221-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312523014221/d412369d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-014221

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer